Health ❯ Healthcare ❯ Clinical Trials

Cancer Research

Immunotherapy Breast Cancer Pancreatic Cancer Prostate Cancer Survival Rates Glioblastoma Patient Outcomes Lung Cancer Therapeutic Innovations Small Cell Lung Cancer

3 ARTICLES

yesterday

AstraZeneca, Daiichi Sankyo and Summit Launch Global Trials of Datroway With Ivonescimab

The agreement pools drug supply, shares trial costs, preserves each company’s commercial rights, launching a Phase III first‑line triple‑negative breast cancer study

4 ARTICLES

last wk.

Oral Vitamin C Shows Biological Signals in Phase 2 EVITA Trial

3 ARTICLES

last mo.

BioNTech Terminates Phase 2 Colorectal Trial of Autogene Cevumeran as Shares Drop

5 ARTICLES

last mo.

Can‑Fite Reports Safe Phase 2a Readout and Survival Signals for Namodenoson in Advanced Pancreatic Cancer

5 ARTICLES

3mo ago

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

5 ARTICLES

3mo ago

Securities Suit Filed Against Grail After NHS‑Galleri Readout Misses Primary Endpoint

5 ARTICLES

3mo ago

Oxford and Moderna Set to Launch Phase‑1 Trial of Preventive mRNA Vaccine for Lynch Syndrome

11 ARTICLES

4mo ago

Amivantamab Injection Eradicates Tumours in Treatment‑Resistant Head and Neck Cancer Trial

6 ARTICLES

4mo ago

FDA Accepts ImmunityBio Filing to Expand ANKTIVA Use in Bladder Cancer

11 ARTICLES

5mo ago

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

4 ARTICLES

5mo ago

NICE Recommends Zanidatamab for NHS Use in HER2-Positive Biliary Tract Cancer

3 ARTICLES

5mo ago

Relacorilant and Pembrolizumab Extend Survival in Platinum-Resistant Ovarian Cancer

5 ARTICLES

6mo ago

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

3 ARTICLES

6mo ago

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

6 ARTICLES

6mo ago

Blood Test Detects Glioblastoma With Over 90% Accuracy as Multi‑Site Trial Begins

3 ARTICLES

7mo ago

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

3 ARTICLES

7mo ago

Oncolytic Viruses Trigger T‑Cell Infiltration and Survival Signals in Early Glioblastoma Trials

Cancer Research

AstraZeneca, Daiichi Sankyo and Summit Launch Global Trials of Datroway With Ivonescimab

Oral Vitamin C Shows Biological Signals in Phase 2 EVITA Trial

BioNTech Terminates Phase 2 Colorectal Trial of Autogene Cevumeran as Shares Drop

Moderna and Merck Report Phase 3 Win for Personalized mRNA Melanoma Therapy

Multiple Plaintiff Firms Seek Lead Role in GRAIL Securities Suit

Experimental UCalgary CAR T Therapy GCAR1 Shrinks Rare Solid Tumours

Can‑Fite Reports Safe Phase 2a Readout and Survival Signals for Namodenoson in Advanced Pancreatic Cancer

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

Securities Suit Filed Against Grail After NHS‑Galleri Readout Misses Primary Endpoint

Oxford and Moderna Set to Launch Phase‑1 Trial of Preventive mRNA Vaccine for Lynch Syndrome

Never miss stories about

Cancer Research

Amivantamab Injection Eradicates Tumours in Treatment‑Resistant Head and Neck Cancer Trial

FDA Accepts ImmunityBio Filing to Expand ANKTIVA Use in Bladder Cancer

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

NICE Recommends Zanidatamab for NHS Use in HER2-Positive Biliary Tract Cancer

Relacorilant and Pembrolizumab Extend Survival in Platinum-Resistant Ovarian Cancer

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

Blood Test Detects Glioblastoma With Over 90% Accuracy as Multi‑Site Trial Begins

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

Oncolytic Viruses Trigger T‑Cell Infiltration and Survival Signals in Early Glioblastoma Trials

Never miss stories about

Cancer Research